MedTrace Logo

Safety and Efficacy of Single Therapy Versus Double and Triple Therapy of the Pellevé™ Wrinkle Treatment System for the Treatment of Moderate Facial Wrinkles

NCT01299103 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-04-15

Study results available
· View outcomes & findings →

Summary

The study will enroll and treat a patients to assess improvement in the appearance of facial wrinkles.

Conditions

  • Appearance of Facial Wrinkles

Interventions

DEVICE

Pelleve Wrinkle Treatment System

comparison of single vs. double and triple treatment with the Pelleve Wrinkle Treatment System

Sponsors & Collaborators

  • Ellman International

    lead INDUSTRY

Principal Investigators

  • Steven H. Dayan, MD · DeNova Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • United States

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01299103 on ClinicalTrials.gov